We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group StudyAuthorsGalanis, Evanthia; Buckner, Jan C.; Maurer, Matthew J.; Kreisberg, Jeffrey I.; Ballman, Karla; Boni, J.; Peralba, Josep M.; Jenkins, Robert B.; Dakhil, Shaker R.; Morton, Roscoe F.; Jaeckle, Kurt A.; Scheithauer, Bernd W.; Dancey, Janet; Hidalgo, Manuel; Walsh, Daniel J.PublicationJournal of Clinical Oncology, 2005, Vol 23, Issue 23, p5294ISSN0732-183xPublication typearticleDOI10.1200/jco.2005.23.622